# Nexus Surgical (NSE: NEXUSSURGL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/NEXUSSURGL · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹10 Cr, it ranks 3902nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the IT sector; its industry is Medical Distribution.

Its return on equity was 46.8% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹2 Cr (+38.5% year on year) and net profit ₹0 Cr (+166.7%), on a standalone basis. Promoters held 18.73% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹10 Cr |
| ROE | 46.8% (FY25) |
| ROCE | 62.8% (FY25) |
| Debt to equity | 0 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹2 Cr | +38.5% | ₹0 Cr | +166.7% | ₹0.44 |
| Q3 FY26 | ₹3 Cr | +98.0% | ₹0 Cr | +54.5% | ₹0.31 |
| Q2 FY26 | ₹1 Cr | +18.2% | ₹0 Cr | −19.0% | ₹0.32 |
| Q1 FY26 | ₹2 Cr | −1.7% | ₹0 Cr | +66.7% | ₹0.28 |
| Q4 FY25 | ₹1 Cr | +146.7% | ₹0 Cr | +50.0% | ₹0.16 |
| Q3 FY25 | ₹1 Cr | +2.1% | ₹0 Cr | +120.0% | ₹0.21 |
| Q2 FY25 | ₹1 Cr | +167.6% | ₹0 Cr | +162.5% | ₹0.38 |
| Q1 FY25 | ₹2 Cr | +66.0% | ₹0 Cr | +200.0% | ₹0.16 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹6 Cr | ₹1 Cr |
| FY24 | ₹3 Cr | ₹0 Cr |
| FY23 | ₹2 Cr | ₹0 Cr |
| FY22 | ₹2 Cr | ₹0 Cr |
| FY21 | ₹4 Cr | ₹0 Cr |
| FY20 | ₹2 Cr | −₹5 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 18.73%
- Non-institutions: 81.27%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Unipro Technolo](https://app.pivotnow.in/stock/UPROTECH) | — | ₹11 Cr | — | — |
| [Catvision](https://app.pivotnow.in/stock/CATVISION) | — | ₹10 Cr | — | — |
| [Otco Intl](https://app.pivotnow.in/stock/OTCO) | — | ₹10 Cr | — | — |
| [ACE ENG](https://app.pivotnow.in/stock/ACEENGITEC) | — | ₹10 Cr | — | — |
| [Cemantic Infra](https://app.pivotnow.in/stock/CEMAINFRA) | — | ₹10 Cr | — | — |
| [Compuage Infocom](https://app.pivotnow.in/stock/COMPINFO) | ₹1.01 | ₹9 Cr | — | — |

## Questions and answers

### What is the market cap of Nexus Surgical?

Nexus Surgical's market capitalisation is ₹10 Cr (₹10 Cr) at the 22 Oct 2026 close, ranking 3902nd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Nexus Surgical?

Return on equity was 46.8% in FY25 and return on capital employed was 62.8% in FY25 (standalone figures).

### Is Nexus Surgical a debt-free company?

Nexus Surgical is close to debt-free: its debt-to-equity ratio was 0 in FY25.

### What were Nexus Surgical's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Nexus Surgical reported revenue of ₹2 Cr, +38.5% year on year, and net profit of ₹0 Cr, +166.7% year on year.

### What is the shareholding pattern of Nexus Surgical?

As of 30 Jun 2026: promoters 18.73%, non-institutions 81.27%.

### Who are Nexus Surgical's competitors?

The listed IT companies closest to Nexus Surgical by market cap are Unipro Technolo, Catvision, Otco Intl, ACE ENG, Cemantic Infra and Compuage Infocom.

### Is Nexus Surgical a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Nexus Surgical's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on NEXUSSURGL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.